Lonza | LONN - Market Capitalization


Lonza reported CHF35.05B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akzo Nobel EUR 8.42B 1.71B Mar/2026
Alcon AG USD 37.06B 5.98B Mar/2026
Almirall EUR 2.76B 472.53M Dec/2025
AstraZeneca USD 301.25B 13.1B Mar/2026
BASF EUR 46.77B 7.11B Mar/2026
Bayer EUR 38.69B 2.33B Mar/2026
Beiersdorf EUR 22.73B 3.43B Dec/2025
Covestro EUR 12.54B 1.53B Dec/2025
Demant DKK 46.01B 10.48B Dec/2025
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Geberit CHF 21.02B 759.86M Dec/2025
Genmab DKK 20.48B 1.02B Dec/2025
Givaudan CHF 29.05B 6.42B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
GN Store Nord DKK 15.22B 890.39M Mar/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Merck EUR 46.78B 6.52B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Philips EUR 22.47B 96.29M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
Sika AG CHF 26.09B 8.47B Dec/2025
Smith & Nephew USD 3.45B 9.87B Jun/2026
Solvay EUR 2.8B 74.11M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025